Clinical Trials on Locally Advanced Pancreatic Neuroendocrine Tumor in Switzerland
Total 222 results
-
University Hospital, Basel, SwitzerlandSwiss National Science Foundation; Paul Scherrer Institute (PSI)RecruitingNeuroendocrine Neoplasia's (NENs) | Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET)Switzerland
-
University Hospital, Basel, SwitzerlandSanofi; Roche Pharma AG; Swiss National Science Foundation; Swiss Cancer LeagueCompletedMetastatic Pancreatic Cancer | Locally Advanced Pancreatic CancerSwitzerland
-
Novartis PharmaceuticalsCompletedAdvanced Neuroendocrine Tumors of Pancreatic OriginCanada, France, United Kingdom, Taiwan, Belgium, Spain, Netherlands, United States, Italy, Sweden, Switzerland, Thailand, Germany, Greece, Korea, Republic of, Japan, Brazil, Slovakia
-
Novartis PharmaceuticalsCompletedMetastatic or Locally Advanced Solid TumorsNetherlands, Spain, Germany, Switzerland, Belgium
-
BayerRecruitingLocally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene FusionUnited States, Austria, Denmark, Germany, Italy, Norway, Spain, United Kingdom, Brazil, Russian Federation, Switzerland, Taiwan, Canada, China, Australia, Greece, Belgium, Sweden, Korea, Republic of, France, Argentina, Finland, Ireland and more
-
University Hospital, Basel, SwitzerlandAnaveon AGRecruiting
-
University Hospital Inselspital, BerneUniversity Hospital, Basel, Switzerland; University of Lausanne Hospitals; University... and other collaboratorsTerminatedGastroenteropancreatic Neuroendocrine TumorsSwitzerland
-
University Hospital, Basel, SwitzerlandUniversity Hospital, Zürich; University Hospital Freiburg; Krebsforschung Schweiz... and other collaboratorsRecruitingThyroid Cancer, Medullary | Neuroendocrine Tumor of the Lung Grade 1 and 2 | Neuroendocrine Tumor of the Thymus Grade 1 and 2 | Neuroendocrine Tumor GEP Grade 1-3Switzerland
-
Novartis PharmaceuticalsTerminatedPancreatic Neuroendocrine Tumors (pNET)United Kingdom, Spain, Netherlands, Italy, Russian Federation, France, Switzerland, United States
-
IpsenCompletedGastroenteropancreatic Neuroendocrine TumorsSwitzerland
-
University Hospital, Basel, SwitzerlandGMP network of BaselCompletedAdvanced MelanomaSwitzerland
-
PIQUR Therapeutics AGCompletedAdvanced Solid TumorsSwitzerland
-
TOLREMO therapeutics AGRecruitingCancer | Adult Solid Tumor | Advanced Solid Tumor | Adult DiseaseSpain, Switzerland
-
Southern Europe New Drug OrganizationPierre Fabre Laboratories; AgennixUnknown
-
Philogen S.p.A.RecruitingAdvanced Solid Tumor | Metastatic Solid TumorItaly, Germany, Switzerland
-
Southern Europe New Drug OrganizationNovartisUnknownAdvanced Solid TumorsSwitzerland
-
Southern Europe New Drug OrganizationCelgene CorporationUnknown
-
Southern Europe New Drug OrganizationNovartis; Schering-PloughUnknownAdvanced Solid TumorsItaly, Switzerland
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors | Recurrent or Refractory Medulloblastoma | Locally Advanced or Metastatic Basal Cell CarcinomaUnited States, United Kingdom, Switzerland, Netherlands
-
T3 Pharmaceuticals AGRecruiting
-
University Hospital Inselspital, BerneCompletedMerkel Cell Carcinoma | Malignant MelanomaSwitzerland
-
PharmaMarCompletedAdvanced Solid TumorsUnited Kingdom, Switzerland
-
Swiss Group for Clinical Cancer ResearchRecruitingAdvanced Solid TumorsSwitzerland
-
Taiho Oncology, Inc.CompletedAdvanced Solid TumorsFrance, Belgium, Italy, Switzerland
-
Dimitri ChristoforidisClinical Trial Unit Ente Ospedaliero CantonaleTerminatedLocally Advanced Rectal CancerSwitzerland
-
Novartis PharmaceuticalsCompletedMetastatic Melanoma and Merkel Cell CarcinomaGermany, Switzerland
-
EMD SeronoMerck KGaA, Darmstadt, GermanyCompletedN-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous MelanomaUnited States, Sweden, Australia, France, Italy, South Africa, Spain, United Kingdom, Germany, Netherlands, Israel, New Zealand, Belgium, Switzerland
-
University Hospital Inselspital, BerneCompletedNeuroendocrine Tumors of the AppendixSwitzerland
-
Felix BeuschleinRadboud University Medical Center; University of Zurich; Ludwig-Maximilians -... and other collaboratorsRecruitingPheochromocytoma | ParagangliomaSwitzerland
-
Gilead SciencesEverest MedicinesActive, not recruitingLocally Advanced or Metastatic Unresectable Urothelial CancerUnited States, Belgium, France, Spain, United Kingdom, Korea, Republic of, Czechia, Germany, Israel, China, Italy, Australia, Hong Kong, Taiwan, Portugal, Singapore, Croatia, Greece, Turkey, Sweden, Switzerland, Canada, Austria, Bulgaria and more
-
University of ZurichCompleted
-
University Hospital, Basel, SwitzerlandActive, not recruitingNeuroendocrine TumorsSwitzerland
-
Prof. Dr. Silke GillessenTerminated
-
University of Lausanne HospitalsFond'action contre le cancer; Barletta Foundation; NCCR (National Center of Competence...Suspended
-
OSI PharmaceuticalsCompletedLocally Advanced or Metastatic Adenoca of the Biliary TractUnited States, Belgium, Germany, Poland, Romania, Switzerland
-
Novartis PharmaceuticalsCompletedAdvanced Solid TumorsSwitzerland, Netherlands, United States, United Kingdom
-
Swiss Group for Clinical Cancer ResearchImmunophotonics, Inc.RecruitingAdvanced Solid TumorsSwitzerland
-
Cytos Biotechnology AGCompletedMalignant MelanomaSwitzerland
-
Agenus Inc.SuspendedAdvanced MelanomaUnited States, Spain, United Kingdom, France, Germany, Switzerland, Belgium, Italy, Brazil, Russian Federation
-
John O. PriorTerminated
-
Centre Hospitalier Universitaire VaudoisImmutep S.A.S.Terminated
-
Hoffmann-La RocheCompletedA Pharmacokinetic and Metabolism Study of 14C-labeled RO5185426 on Patients With Metastatic MelanomaMalignant MelanomaSwitzerland
-
University of ZurichCompleted
-
Centre Hospitalier Universitaire VaudoisCompletedOcular MelanomaSwitzerland
-
Debiopharm International SARecruitingAdvanced Solid TumorsSpain, United States, Switzerland
-
Centre Hospitalier Universitaire VaudoisLudwig Institute for Cancer ResearchCompleted
-
Novartis PharmaceuticalsCompletedAdvanced Solid TumorsSwitzerland, Sweden, Netherlands, United States, United Kingdom
-
University Hospital Inselspital, BerneCompleted
-
Centre Hospitalier Universitaire VaudoisActive, not recruitingMetastatic MelanomaSwitzerland
-
Centre Hospitalier Universitaire VaudoisLudwig Institute for Cancer ResearchCompleted